We validated the molecular characteristics of this cell line by portraying the expression profiles of ER and ErbB2 and comparing them to those of two other breast cancer cell lines: MCF-7, which corresponds to a luminal subtype, and SKBR3, which corresponds to HER2 (ErbB2)-enriched subgroups. This evidence concerns the gene ERBB2 and breast cancer.